JANX

Janux Therapeutics
JANX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.87B
EV
$866.76M
Shares Outstanding
64.38M
Beta
3.26

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$85.33
P/E 2025E
-
P/Revenue 2025E
247.02x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Janux Therapeutics, Inc.

gainify
JANX

Janux Therapeutics, Inc.

JANX

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) platforms technology to treat patients suffering from cancer. The company’s c...

Sector

Healthcare

Industry

Biotechnology

CEO

Campbell, David

Employees

81

IPO Date

2021-06-11

Headquarters

10955 Vista Sorrento Parkway, Suite 200, San Diego, California, 92130, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved